$ORMP
Oramed Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOramed Pharmaceuticals Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is ORMP down today? It is at $4.37 (-0.23%), and our scanner flagged it 9 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ORMP spikes, and full due diligence on ORMP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ORMP 9 times in the last 30 days. Create a free account to track $ORMP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ORMP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ORMP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hexter Joshua Officer | Sold (automatic/other) | -30K 0.07% of company | sold 2.2% | 1.33M | $135K at $4.51 | Oct 1, 26 |
Gabay Avraham Officer | Sold (automatic/other) | -20K 0.05% of company | sold 2.3% | 861K | $90K at $4.51 | Oct 1, 26 |
Gabay Avraham Officer | Acquired (grant/award) | +209K 0.5% of company | added 31% | 881K | n/a | Sep 24, 26 |
Kidron Miriam Officer | Acquired (grant/award) | +417K 1.0% of company | added 37% | 1.55M | n/a | Sep 24, 26 |
Hexter Joshua Officer | Acquired (grant/award) | +285K 0.7% of company | added 27% | 1.36M | n/a | Sep 24, 26 |
Kidron Nadav Officer | Acquired (grant/award) | +718K 1.7% of company | added 21% | 4.14M | n/a | Sep 24, 26 |
Hexter Joshua Officer | Other | 50K 0.1% of company | added 4.9% | 1.07M | $185K at $3.69 | Jul 2, 26 |
Gabay Avraham Officer | Sold (automatic/other) | -73K 0.2% of company | sold 9.8% | 672K | $331K at $4.51 | Jul 1, 26 |
Hexter Joshua Officer | Sold (automatic/other) | -137K 0.3% of company | sold 12% | 1.02M | $611K at $4.46 | Jul 1, 26 |
Kidron Miriam Officer | Sold (automatic/other) | -435K 1.0% of company | sold 28% | 1.13M | $1.4M at $3.31 | Mar 30, 26 |
Kidron Nadav Officer | Sold (automatic/other) | -45K 0.1% of company | sold 1.3% | 3.42M | $148K at $3.31 | Mar 30, 26 |
Gabay Avraham Officer | Acquired (grant/award) | +96K 0.2% of company | added 15% | 745K | n/a | Mar 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ORMP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ORMP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ORMP last traded at $4.37, down 0.23% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Oramed Pharmaceuticals Inc. (ORMP) is next expected to report earnings on Thursday, November 12, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ORMP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ORMP 9 times in the last 30 days.
ORMP (Oramed Pharmaceuticals Inc.) trades on XNAS, with a market cap of about $182M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ORMP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ORMP discussion
Sign in to ask a question or join the discussion.